<DOC>
	<DOCNO>NCT03068988</DOCNO>
	<brief_summary>The prospective randomize clinical study investigate effect mesenchymal stem cell tendon healing . The objective study demonstrate effect concentrate bone marrow stem cell ( MSCs ) healing suture tendon supraspinatus muscle comparison procedure perform without MSCs . We postulate hypothesis MSCs enhance healing suture supraspinatus tendon humeral footprint .</brief_summary>
	<brief_title>Clinical Study Mesenchymal Stem Cells Used Reconstruction Surgery Supraspinatus Muscle Lesions</brief_title>
	<detailed_description>The prospective randomized study carry orthopaedic traumatology , haematology radiology department . 50 patient include study . Of 25 patient group , Group I ( receive concentrate marrow MSCs tendon- bone contact point site suture surgery ) consist 7 woman 18 men ( mean age 51,2 year ) , Group II ( without use MSCs ) consist 15 woman 10 men ( mean age 50,5 year ) . Selection patient group perform use permutation block randomization computer software Random Number Generator Software 7.0 . All radiographs/MRI/CT result evaluate experienced radiologist specialize musculoskeletal pathology , blind group patient . Before enter study , patient sign informed consent create Ethical Committee local hospital randomly assign one treatment possibility use Random Number Generator Software 7.0 method 1:1 . Before surgical treatment , patient complete questionnaire VAS score , ASES score ( American Shoulder Elbow Surgeons Standardized Shoulder Assessment Form ) Constant score . Further clinical control complete questionnaire 6 month surgery , 1 year surgical treatment , 2 , 5 ten year postoperatively . Two year surgery MRI examination shoulder joint perform . All outpatient clinical evaluation study perform orthopaedic surgeon blind group patient . The actual therapy follow : open surgery precede standard diagnostic arthroscopy , perform posterior portal optic anterior portal arthroscopic instrument . The tendon rotator cuff assess side - intraarticular subacromial . To evaluate cuff tendon injury perioperatively measure rupture width , special arthroscopic hook calibrate 1 mm use . To evaluate shape rupture , classification Ellman - Gartsman use . Surgical treatment injured tendon rotator cuff perform beach chair position patient , deltoid muscle split approach . After evaluation extent location cuff tendon lesion aspiration 10 ml bone marrow blood do ( humeral head surgical approach ) 20 mL syringe prefilled 0.5 ml heparin Yamshidi needle . Aspiration bone marrow perform surgeon . From one bone puncture aspirate maximally 3 ml marrow blood . Centrifugation aspirate 10 ml test-tube Monovette fill citrate follow . Selected centrifugation regime consist gradient 15 minute centrifugation 200 g RCF ( relative centrifugal force ) . After centrifugation tube content divide three part . The upper layer consist platelet-rich plasma ( PRP ) , middle layer buffy coat dominant proportion leukocyte , low layer form sedimented erythrocyte . Using sterile laboratory pipette , collection buffy coat perform . MSCs represent 0.01 0.02 % nuclear element buffy coat , 10 x 106 / l. The MSCs concentrate ( similar synovial fluid consistency colour ) impregnate collagen patch Hypro-Sorb F ( Otrokovice , Czech Republic ) dimension 1x2 cm . The collagen patch carrier MSCs concentrate use ensure retention desired place . This material insert tendon bone , place re-fixing rotator cuff tendon ( footprint ) tighten threads anchor . Fixation tendon bone make double row method use absorbable fixation anchor BioComposite Corkscrew ( Arthrex , Munich , Germany ) . In treated case tendon fixed place original attachment without stress without need abduction arm 60 degree . All patient underwent Neer acromioplasty increase subacromial space . This procedure follow standard surgical wound closure anatomical layer , sterile dress wound apply abduction orthosis . All patient operate orthopaedic surgeon surgical technique . Open surgery instead arthroscopy choose safe fixation MSCs carrier re-inserted tendon reduce risk washout MSCs concentrate carrier arthroscopy . Surgical treatment patient Group II identical Group I , except aspiration bone marrow humeral head subsequent application scaffold saturate MSCs tendon / bone interface . Abduction fixation last 4 week . Passive motion horizontal line guidance physiotherapeutist initiate first postoperative day . After remove fixation , active rehabilitation begin , full range motion exercise do actively 6 week surgery . Full load allow 12 week surgery . Outpatient follow-up take place accord schedule mention . To check integrity tendon point insertion great tuberosity humerus , MRI shoulder joint perform 2 year postoperatively . Both , preoperative postoperative MRI examination perform 1.5T high-field scanner , sagittal , coronal , axial plane , T1- T2-weighted fat-saturated sequence ( MRI arthrography use gadollinium contrast medium ) . All MRI result evaluate experienced radiologist specialize musculoskeletal pathology . He evaluate tendon integrity , presence localisation complete retear , tendon muscle border , presence abnormal artifact . The primary hypothesis study use mesenchymal stem cell supraspinatus tendon reconstruction surgery positive effect assessment subjective objective score system , also term reduce number tendon reruptures compare patient population mesenchymal stem cell use . All data statistically analyze STATISTICA 9.0 programme . To compare result VAS score , Constant score , ASES score preoperatively one year surgery StudentÂ´s t- test use , compare incidence reruptures group patient 2 year postoperatively Chi-square test use . The significance level determine p &lt; 0.05 . Patients randomly assign one treatment possibility use Random Number Generator Software 7.0 method 1:1</detailed_description>
	<criteria>men woman age 1860 year chronic supraspinatus tendon tear great 50 % width history trauma examine shoulder girdle confirmation clinical examination preoperative imaging examination ( MRI arthrography ) sign informed consent minimum preoperative haemoglobin concentration men 13.8 g / dl , woman 12.1 g / dl previous surgical treatment rotator cuff cuff tear arthropathy grade 35 accord Hamada fatty degeneration cuff muscle ( Goutallier 3 4 ) atrophy supraspinatus muscle accord Thomazeau classification grade II III retraction supraspinatus muscle tendon Patte III pregnancy active infection surgical site elsewhere body osteomyelitis sepsis history diabetes steroid use chemotherapy use NSAIDs radiation hepatitis HIV hemato / oncological disease alcohol abuse drug abuse cigarettes medical condition affect growth bone connective tissue ( osteomalacia metabolic bone disease ) vascular insufficiency operate extremity muscle atrophy neuromuscular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>bone marrow stem cell</keyword>
	<keyword>rotator cuff lesion</keyword>
</DOC>